Prospective, Single-Arm, Multicenter, Open-Label Study to Investigate the Efficacy and Tolerability of the Once Daily (OD) Memantine Treatment.

Trial Profile

Prospective, Single-Arm, Multicenter, Open-Label Study to Investigate the Efficacy and Tolerability of the Once Daily (OD) Memantine Treatment.

Completed
Phase of Trial: Phase III

Latest Information Update: 31 Oct 2011

At a glance

  • Drugs Memantine (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Sponsors Merz Pharmaceuticals GmbH
  • Most Recent Events

    • 08 Dec 2008 Actual patient number (107) added as reported by ClinicalTrials.gov.
    • 08 Dec 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 26 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top